Home > Insider Trading > Abbott Laboratories

Abbott Laboratories (ABT)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
221 - 230
Next >>

Was The Smart Money Right About Abbott Laboratories (ABT)?

After several tireless days we have finished crunching the numbers from nearly 900 13F filings issued by the elite hedge funds and other investment firms that we track at Insider Monkey, which disclosed...

Keep Reading →

November 2nd, 2021 - Hedge Funds News

5 Best Diabetes Stocks To Buy Now

Abbott Laboratories (NYSE:ABT) is a $225 billion medical device company that sells diabetes care products including blood glucose monitoring systems and diabetes management systems.

Keep Reading →

November 2nd, 2021 - Hedge Funds News

5 Dividend Stocks to Buy According to Mark Coe's Coe Capital Management

In this article, we discuss the top 5 dividend stocks to buy according to Mark Coe’s Coe Capital Management.

Keep Reading →

October 24th, 2021 - Hedge Funds News

5 Stocks Making Moves on Financial Results

In this article, we discuss the 5 stocks making moves on financial results.

Keep Reading →

October 21st, 2021 - News

10 Best Big Pharma Stocks to Buy Now

On September 9, the United States Department of Health and Human Services (HHS) unveiled a comprehensive plan to reduce drug prices.

Keep Reading →

October 8th, 2021 - Hedge Fund Analysis News

Hedge Funds Are Selling Abbott Laboratories (ABT)

Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips or bumps on the charts usually don't make them change their opinion towards a...

Keep Reading →

September 28th, 2021 - Hedge Funds News

5 Best Stocks to Buy According to Ric Dillon's Diamond Hill Capital

In this article, we will discuss 5 best stocks to buy according to Ric Dillon's Diamond Hill Capital based on Q2 holdings of the fund.

Keep Reading →

September 13th, 2021 - Hedge Funds News

Polen Focus Growth: "Abbott Laboratories (ABT) was the Lone Detractor in the Quarter"

Polen Capital, an investment management firm, published its “Polen Focus Growth” second quarter 2021 investor letter – a copy of which can be downloaded here.

Keep Reading →

August 26th, 2021 - Hedge Fund Investor Letters News

10 Best No-Fee DRIP Stocks to Buy Now

In this article, we will be taking a look at the 10 best no-fee DRIP stocks to buy now.

Keep Reading →

August 25th, 2021 - Hedge Funds News

Should You Consider Investing in Abbott Laboratories (ABT)?

Baron Funds, an asset management firm, published its “Baron Health Care Fund” second quarter 2021 investor letter – a copy of which can be downloaded here.

Keep Reading →

August 18th, 2021 - Hedge Fund Investor Letters News